Metoprolol Hexal

Metoprolol succinate, the active ingredient in Metoprolol Hexal, is a beta blocker presented as an oral tablet for oral use. It reduces heart rate and cardiac output, and is employed to manage hypertension, angina pectoris and chronic heart failure in adult patients.

GNH USA supplies Metoprolol Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other health‑care institutions worldwide. The company adheres to stringent quality standards and provides regulatory support for cross‑border distribution, ensuring product integrity.

Metoprolol Hexal, a selective β1‑adrenergic blocker, is used in several cardiovascular conditions.

- Hypertension: lowers blood pressure by decreasing cardiac output and inhibiting renin release. - Angina pectoris: reduces myocardial oxygen demand through heart‑rate and contractility control. - Chronic heart failure: improves survival and symptoms by decreasing ventricular workload. - Post‑myocardial infarction: lowers risk of recurrent ischemic events and arrhythmias.

Metoprolol Hexal may cause a range of adverse reactions.

Common Side Effects: - Fatigue: feeling unusually tired or weak. - Dizziness: light‑headedness, especially when standing quickly. - Bradycardia: slower than normal heart rate. - Cold extremities: reduced blood flow to hands and feet. - Gastrointestinal upset: nausea or abdominal discomfort. - Depression: low mood or loss of interest.

Serious or Rare Side Effects: - Severe bradycardia or heart block requiring medical attention. - Marked hypotension leading to fainting. - Bronchospasm in patients with reactive airway disease. - Acute heart failure exacerbation. - Allergic reactions such as rash, itching, or swelling. - Cardiogenic shock in rare cases.

Before initiating therapy, clinicians should consider several safety aspects.

- Monitor blood pressure: ensure adequate control without excessive lowering. - Assess heart rate: watch for bradycardia, especially in patients with conduction disorders. - Use caution in asthma or COPD: β1‑selectivity may still affect bronchial tone. - Avoid abrupt discontinuation: taper gradually to prevent rebound tachycardia or hypertension. - Adjust dose in renal impairment: reduced clearance may require lower dosing. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Metoprolol Hexal can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Verapamil or diltiazem: combined negative chronotropic effect may cause severe bradycardia. - Clonidine withdrawal: abrupt cessation while on metoprolol can precipitate hypertensive crisis.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance hypotensive effect; monitor blood pressure. - Diuretics: additive blood‑pressure lowering; watch for electrolyte disturbances. - NSAIDs: may reduce antihypertensive efficacy; assess renal function and blood pressure.